Microelectronic medical implant is any sort of medical device that involves microelectronic components and is placed inside the body of the patient to achieve the desired physiological response. The microelectronic medical implants market has come a long way since the introduction of the first pacemaker in the 1970s.
Some of the major products such as neurostimulators have derived their technology directly from that of pacemakers. Other devices such as drug infusion pumps have been developed on sensors-on-chip technology and miniaturization of mechanical components and circuitry of medical devices.
The global microelectronic implants market is estimated to generate multi-billion business in the next five years. Microelectronic medical technology evolving to be safe and with better efficacy and thus promises a huge market for commercialization of such devices across the globe. Several devices which are in the pipeline to be approved by the regulatory associations worldwide further enhance the market opportunities.
Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=931
A variety of medical implants employ microelectromechanical systems (MEMS) technology and the scope of these devices is increasing as large-scale research and development in this technology is taking place. The major applications of microelectronic medical technology are in cardiac implants such as pacemakers and defibrillators, neurostimulators, spinal fusion stimulators, implantable drug pumps, hearing implants, eye implants and others.
Neurostimulators are used in a wide variety of implants such as in pain management implants, cochlear stimulators, drug delivery, and brain monitors in neurological disorders. Many such implants are asserted to be biocompatible with the human body so that they would last longer and their efficacy would not wane. The latest devices are so designed that they would dissipate minimal power.